Endoplasmic Reticulum Stress Nano-Orchestrators for Precisely Regulated Immunogenic Cell Death as Potent Cancer

Yulu Teng1, Zhenzhen Yang1,2, Yiwei Peng1

  • 1Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery System, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, China.

PubMed

Insights

A novel nano-orchestrator precisely controls endoplasmic reticulum (ER) stress to optimize immunogenic cell death (ICD) for cancer vaccines. This approach enhances immune responses and achieves a 100% success rate in preventing tumor recurrence in vivo.

Area of Science:

  • Biomedical Engineering
  • Cancer Immunology
  • Nanotechnology

Background:

  • Immunogenic cell death (ICD) inducers are promising for cancer vaccines due to broad antigen presentation.
  • Clinical translation is limited by low immunogenicity and potential tumorigenicity of ICD-induced tumor cells.

Purpose of the Study:

  • To develop a nano-orchestrator targeting endoplasmic reticulum (ER) stress to optimize ICD for cancer vaccines.
  • To precisely regulate the dose of ER stress for enhanced cancer vaccine efficacy.

Main Methods:

  • Utilized an 808 nm laser with a clinical-range irradiation fluence (50–200 J cm⁻²) to trigger ER stress.
  • Employed a nano-orchestrator to modulate ER stress and regulate the release of damage-associated molecular patterns (DAMPs) and antigens.
  • Investigated the protein kinase R-like endoplasmic reticulum kinase (PERK)-C/EBP homologous protein (CHOP) pathway.

Main Results:

  • A specific laser fluence (150 J cm⁻²) significantly increased dendritic cell maturation and antitumor T cell proliferation.
  • The nano-orchestrator enhanced adjuvanticity and antigenicity by regulating ICD-induced DAMPs and promoting tumor cell apoptosis via the PERK-CHOP pathway.
  • Optimized phototherapeutic dying tumor cells demonstrated a 100% success rate in prophylactic vaccination against tumor rechallenge in vivo.

Conclusions:

  • Optimized ER stress via the nano-orchestrator effectively generates potent cancer vaccines from dying tumor cells.
  • This strategy holds potential for developing in situ therapeutic tumor vaccines when combined with immune checkpoint inhibitors like anti-PD-L1.
  • The findings offer insights into enhancing cancer immunotherapy by modulating endogenous immune responses.

Related Concept Videos

Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.3K
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
1.6K
The Unfolded Protein Response01:37

The Unfolded Protein Response

The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
4.4K